Novavax Reports Encouraging Vaccine Resu
05 Aug, 2020

Novavax, a biotechnology company that received $1.6 billion from the federal government to test its coronavirus vaccine .....

Read More
Novavax begins mid-stage study of COVID-
18 Aug, 2020

U.S. drug developer Novavax Inc (NVAX.O) said on Monday it started a mid-stage study of its experimental COVID-19 vaccin.....

Read More
Companies testing vaccines pledge safety
08 Sept 2020

The top executives of nine drugmakers likely to produce the first vaccines against the new coronavirus signed an unprece.....

Read More
How pharma companies can still deliver a
13 Sept, 2020

NEW YORK: As questions mount over whether the United States will authorize a coronavirus vaccine ahead of November elect.....

Read More
When will COVID-19 vaccines be generally
18 Sept, 2020

U.S. President Donald Trump and the head of the Centers for Disease Control and Prevention (CDC) on Wednesday disagreed .....

Read More
Oxford COVID-19 vaccine: Serum Institute
19 Sept, 2020

-The phase III trial of 'Covishield' vaccine will begin at Sassoon hospital from next week, said Dr Muralidhar T.....

Read More
Novavax initiates late-stage covid-19 va
26 Sept, 2020

Novavax Inc on Thursday started a late-stage trial of its experimental COVID-19 vaccine in the United Kingdom in partner.....

Read More
The race for COVID-19 vaccine: Why this
02 Oct, 2020

October is a critical month in the race for a Covid-19 vaccine, with developments that could lead to some Americans gett.....

Read More
Oxford covid vaccine seen effective in e
26 Oct, 2020

- The Oxford covid vaccine is considered a frontrunner in the race to Covid-19 vaccine. - The outcome of the trials is .....

Read More
Sanofi, GSK to supply vaccine doses to W
28 Oct, 2020

PARIS (Reuters) - French drugmaker Sanofi SASY.PA and Britain's GlaxoSmithKline GSK.L will supply 200 million doses .....

Read More
Novavax delays U.S. trial of COVID-19 va
28 Oct, 2020

FILE PHOTO: A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in th.....

Read More
Next crop of COVID-19 vaccine developers
29 Oct, 2020

CHICAGO/BERLIN (Reuters) - The handful of drugmakers dominating the global coronavirus vaccine race are pushing the boun.....

Read More
Japan's Takeda to import 50 million dose
29 Oct, 2020

TOKYO (Reuters) - Japan’s Takeda Pharmaceutical Co said on Thursday it would import and distribute 50 million dose.....

Read More
Japan's Shionogi readies COVID-19 vaccin
29 Oct, 2020

TOKYO (Reuters) - Shionogi & Co is planning clinical trials by year-end for what may be one of Japan’s first d.....

Read More
Australia secures 50 million doses of CO
05 Nov, 2020

Two more COVID-19 vaccines have been secured for the Australian population under new agreements NEW DELHI, November 5.....

Read More
India’s top vaccine producer, Se
26 Nov 2020

Besides their visit to vaccine manufacturing facilities of Serum Institute of India, top diplomats will also make a halt.....

Read More
India biggest buyer of covid-19 vaccine
05 Dec 2020

NEW DELHI : India is the largest buyer of COVID-19 vaccines in the world with 1.6 billion doses, according to a global a.....

Read More
Not without India. Pharma sector to play
11 Dec 2020

India, the world's biggest vaccine maker, is getting set for the massive global blitz to contain the coronavirus pan.....

Read More
Novavax enters deal with New Zealand for
17 Dec, 2020

(Reuters) - Biotechnology company Novavax Inc said it had entered an agreement with the government of New Zealand for 10.....

Read More
Serum Institute of India to make 300 m
29 Dec 2020

Adar Poonawalla, COO, SII, said they have a stockpile of 40-50 million doses already and more are being produced every w.....

Read More
Serum Institute expects WHO emergency ap
15 Jan, 2021

The Serum Institute of India expects WHO emergency-use authorization soon for the Oxford University/AstraZeneca coronavi.....

Read More
Exclusive: Saudi Arabia to get three mil
27 Jan, 2021

NEW DELHI (Reuters) - The Serum Institute of India (SII) will supply Saudi Arabia with 3 million AstraZeneca COVID-19 va.....

Read More
Novavax vaccine seems effective against
29 Jan, 2021

Novavax Inc said Thursday that its COVID-19 vaccine appears 89 per cent effective based on early findings from a British.....

Read More
Serum seeks regulatory nod for second Co
30 Jan, 2021

Vaccine maker Serum Institute of India (SII) has sought regulatory approval for carrying out trials in India for its sec.....

Read More
J&J vaccine adds to COVID-19 arm
30 Jan, 2021

(Reuters) - Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective in preventing COVID-19 i.....

Read More
Covid-19: Serum Institute of India to la
01 Feb, 2021

Vaccine maker Serum Institute of India (SII) will be launching its second Covid-19 vaccine in June 2021. Adar Poonawalla.....

Read More
WHO-led COVAX vaccine scheme agrees new
04 Feb, 2021

GENEVA/LONDON (Reuters) - India’s Serum Institute will supply 1.1 billion doses of COVID-19 vaccines developed by .....

Read More
10 Feb, 2021

The head of the World Health Organization said Monday the emergence of new COVID-19 variants has raised questions about .....

Read More
Covid-19: Virus may never go away but co
15 Feb, 2021

What if COVID-19 never goes away? Experts say it’s likely that some version of the disease will linger for years. .....

Read More
Covid-19 vaccine: SII to supply 20 milli
17 Feb, 2021

Serum Institute of India (SII) has received approval from the World Health Organization (WHO) to supply the AstraZeneca-.....

Read More
Novavax to provide 1.1 billion COVID-19
20 Feb, 2021

Novavax on Friday has agreed to supply 1.1 billion doses of its experimental coronavirus vaccine in nearly 200 low and m.....

Read More
Covishield: Asked to prioritise for Indi
22 Feb, 2021

The Indian government has directed vaccine maker, Serum Institute of India (SII) to prioritise for meeting the Covid-19 .....

Read More
Chinese hackers target Indian vaccine ma
02 March, 2021

NEW DELHI (Reuters) - A Chinese state-backed hacking group has in recent weeks targeted the IT systems of two Indian vac.....

Read More
Indias manufacturing base is playing a c
03 March, 2021

On Tuesday, the governments of Côte d’Ivoire and Ghana started COVID-19 vaccination campaigns which are focu.....

Read More
Clinical trials underway to test jab eff
04 March, 2021

Clinical trials are now underway to test the safety and efficacy of covid-19 vaccines for children, the Union health min.....

Read More
US export curbs can limit COVID-19 vacci
06 March, 2021

The production of coronavirus vaccines and scaling up global availability could be seriously limited due to ban on expor.....

Read More
Study of coronavirus variants predicts v
09 March, 2021

A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal an.....

Read More
Trial for second SII Covid vaccine begin
27 March, 2021

The clinical trial for the second Covid-19 vaccine being manufactured by Serum Institute of India (SII), developed by US.....

Read More
Serum - new Covid-19 vaccines yet to ge
15 April 2021

The new vaccine approval norms in the country are unlikely to speed up the launch of new Covid-19 vaccines from Serum In.....

Read More
Biological E may launch vaccine by Augus
22 April 2021

NEW DELHI : Biological E Ltd is about to complete phase 1 and 2 trials of its covid-19 vaccine and is expected to launch.....

Read More
India - biggest Serum Vaccine order cove
04 May, 2021

The Narendra Modi-led federal government hasn’t placed an order larger than 110 million doses from the biggest loc.....

Read More
Novavax combined influenza/COVID-19 vacc
11 May, 2021

Novavax Inc said on Monday its combined flu and COVID-19 vaccine produced functional antibodies against influenza and th.....

Read More
US removes DPA ratings on AstraZeneca, N
05 June, 2021

Confident of the availability of Covid-19 vaccines in the country, the Biden Administration has removed Defense Producti.....

Read More
Serum Institute to make 3 types of Covid
07 June, 2021

Pune-based Serum Institute of India (SII), which has been the largest producer of vaccines in India, making the Oxford-A.....

Read More
Novavax: Large study finds COVID-19 shot
15 June, 2021

Vaccine maker Novavax said Monday its shot was highly effective against COVID-19 and also protected against variants in .....

Read More
Novavax Covid-19 vaccine Covavax to laun
18 June, 2021

The Serum Institute of India (SII) hopes to introduce US firm Novavax's Indian version of the Covid-19 vaccine - .....

Read More
Covid-19: Serum to start making Sputnik
14 July, 2021

Serum Institute of India (SII) and Russian Direct Investment Fund (RDIF) on Tuesday said production of the Sputnik V vac.....

Read More
EU begins real-time review of Sanofi-GSK
22 July, 2021

Europe's drug regulator said on Tuesday it had started a real-time review of the Covid-19 vaccine developed by Frenc.....

Read More
Novavax seeks OK for COVID vaccine in ne
06 Aug, 2021

Vaccine maker Novavax announced Thursday it has asked regulators in India, Indonesia and the Philippines to allow emerge.....

Read More
Hopeful of launching Covovax for adults
06 Aug, 2021

Serum Institute of India CEO Adar Poonawalla on Friday said he is hopeful that Covovax, another COVID-19 vaccine being m.....

Read More
COVID-19: Pfizer, Moderna seen reaping b
14 Aug, 2021

Drugmakers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID-19 booster shots in .....

Read More
Covid vaccination for kids may start onl
21 Aug, 2021

NEW DELHI: The government is likely to start vaccination of children against Covid-19 only by March 2022, even as three-.....

Read More
Novavax expects to make available at lea

Sept 10 (Reuters) - Vaccine developer Novavax Inc (NVAX.O) said on Friday at least 2 billion doses of its COVID-19 vacci.....

Read More
Novavax expects to make available at lea

Vaccine developer Novavax Inc (NVAX.O) said on Friday at least 2 billion doses of its COVID-19 vaccine would be availabl.....

Read More
Novavax, SII apply to WHO for emergency

It represents another major milestone in Novavax’s transformation into a commercial global vaccine company and rei.....

Read More